Luisa Beltran

Iterable said March 20 that it raised $50 million in Series C funding. Blue Cloud Ventures, CRV, Harmony Partners, Index Ventures and Stereo Capital participated in the round. Iterable is a growth marketing platform for cross-channel customer engagement.

Edison Partners said March 20 that it led a $26 million funding round for NS8, an ecommerce security and website performance company.

Point said March 20 that it raised $122 million Series B funding led by Prudential Financial and DAG Ventures. New investors include Financial Venture Studio and Enterprise Community Partners, while existing investors Andreessen Horowitz, Ribbit Capital, and Bloomberg Beta​ participated. Kingsbridge Wealth Management, which took part in the equity round, is providing a $100 million platform capital commitment. Point, of Palo Alto, California, buys equity in American homes.

Dorian said March 19 that it raised $2 million in seed funding led by March Capital Partners. London Venture Partners participated in the round. Dorian is an immersive fiction app that aims to deliver interactive storytelling.

Trovata.io said March 19 that Joseph Drambarean has joined as chief technology while Dave McCutcheon  has joined as vice president of sales. Drambarean was most recently at Capital One, where he led product management as head of the innovation labs and mobile banking teams. McCutcheon is the former head of sales and alliances at FloQuast.

Marketing Evolution said March 19 that it raised $26.1 million in growth financing led by Energy Impact Partners. Existing investors Insight Venture Partners and Zetta Venture Partners participated in the round. Marketing Evolution provides marketing measurement and optimization solutions.

OneWeb said March 18 that it raised $1.25 billion in new capital led by SoftBank Group Corp, Grupo Salinas, Qualcomm Technologies Inc, and the government of Rwanda. OneWeb is a global communications company.

Theranica said March 18 that it raised $35 million in a Series B round led by aMoon. All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in the round. Theranica is a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases.

Karuna Therapeutics Inc said March 18 that it raised a $68 million Series B round led by ARCH Venture Partners. Participating in the round were Fidelity Management & Research Co, Eventide Asset Management, Pivotal bioVenture Partners, Partner Fund Management, Wellcome Trust, Sands Capital, Alexandria Venture Investments, and founder PureTech Health. Karuna focuses on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders including psychosis in schizophrenia, psychosis in Alzheimer’s disease, and pain. Karuna, with the $68 million round, plans to issue $5 million in shares upon conversion of debt into equity.

Imara Inc said March 18 that it raised $63 million in a Series B financing round co-led by OrbiMed Advisors and Arix Bioscience plc. Participating were RA Capital and Rock Springs Capital. Existing investors New Enterprise Associates, Pfizer Venture Investments, Lundbeckfonden Ventures, Bay City Capital, and Alexandria Venture Investments also took part. Imara is a clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies.